The content is available as a PDF (358.8 KB).
editorial . 2021 Jul 15:ciab635. doi: 10.1093/cid/ciab635
Candidemia and Severe COVID-19 – Which Risk Factors are Modifiable?
Todd McCarty
1,✉
Todd McCarty
1University of Alabama at Birmingham, Birmingham, Alabama, United States
Find articles by Todd McCarty
1University of Alabama at Birmingham, Birmingham, Alabama, United States
✉
Corresponding Author: Todd McCarty, University of Alabama at Birmingham, Birmingham, Alabama, UNITED STATES, tmccarty@uabmc.edu
Received 2021 Jul 1.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC8344596 PMID: 34265057
See commentary "The landscape of candidemia during the COVID-19 pandemic." with doi: 10.1093/cid/ciab562.